Learn more

AMYLIN PHARMACEUTICALS INC

Overview
  • Total Patents
    748
  • GoodIP Patent Rank
    241,543
About

AMYLIN PHARMACEUTICALS INC has a total of 748 patent applications. Its first patent ever was published in 1988. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are JIANGSU HAOSEN PHARMACEUTICAL, FERRING FARMA LAB and AMYLIN PHARMACEUTICALS LLC.

Patent filings per year

Chart showing AMYLIN PHARMACEUTICALS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Young Andrew A 160
#2 Prickett Kathryn S 101
#3 Parkes David G 74
#4 Ghosh Soumitra S 68
#5 Young Andrew 66
#6 Mack Christine M 63
#7 Soares Christopher J 62
#8 Jodka Carolyn M 61
#9 Beeley Nigel Robert Arnold 57
#10 Hanley Michael R 55

Latest patents

Publication Filing date Title
CN103957926A Engineered polypeptides having enhanced duration of action and reduced immunogenicity
CN103906528A Methods for treating diabetes with extended release formulations of GLP-1 receptor agonists
WO2012088157A2 Glp-1 receptor agonists for islet cell transplantation
CN103370083A Engineered polypeptides having enhanced duration of action
WO2012036962A2 C-terminal amidation of polypeptides
WO2011156407A2 Glp-1 receptor agonists to treat pancreatitis
WO2011085239A1 Hypodermic needle assembly having a transition hub for enhancing fluid dynamics and microsphere injectability
WO2011063414A1 Polypeptide conjugate
WO2011056713A2 Glp-1 receptor agonist compounds for obstructive sleep apnea
WO2011050008A2 Combination therapy comprising administration of an amylinomimetic and a pyy peptidomimetic for effecting weight loss and for treating obesity and related metabolic conditions and disorders
EP2435061A1 Glp-1 receptor agonist compounds for sleep enhancement
EP2413955A2 N-terminus conformationally constrained glp-1 receptor agonist compounds
WO2010107874A2 Methods for affecting body composition using amylin agonists
US2011263496A1 Exendins to lower cholesterol and triglycerides
EP2288918A1 Glp-1 receptor agonist bioassays
JP2009149684A Preparation for amylin agonist peptide
US2009203603A1 Compositions for the Treatment and Prevention of Nephropathy
EP2195034A2 Peptide-peptidase inhibitor conjugates and methods of making and using same
EP2170437A2 Pen injection device and method of using same
WO2008134570A2 Mixing tool